The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function

BACKGROUND: In patients with multiple myeloma, renal impairment (RI) at the time of diagnosis is associated with poor survival. To the authors' knowledge, the current retrospective analysis presented is the first to assess the impact of various degrees of renal dysfunction on safety and efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Dimopoulos, Meletios, Alegre, Adrian, Stadtmauer, Edward A, Goldschmidt, Hartmut, Zonder, Jeffrey A, de Castro, Carlos M, Masliak, Zvenyslava, Reece, Donna, Olesnyckyj, Marta, Yu, Zhinuan, Weber, Donna M
Formato: Texto
Lenguaje:English
Publicado: Wiley Subscription Services, Inc., A Wiley Company 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970911/
https://www.ncbi.nlm.nih.gov/pubmed/20564094
http://dx.doi.org/10.1002/cncr.25139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970911/
https://www.ncbi.nlm.nih.gov/pubmed/20564094
http://dx.doi.org/10.1002/cncr.25139

Ejemplares similares